{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:57:20Z","timestamp":1788976640663,"version":"build-2803163510"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"SI2","license":[{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Japan Society of Allergology, Mochida Memorial Foundation, and Gushinkai"},{"name":"Ho Family Chair in Autoimmune Diseases"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To assess whether there are identifiable subgroups of disease activity trajectory in a population of JDM patients\u2014followed throughout childhood and into adulthood\u2014and determine factors that predict those trajectory groupings.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This is a retrospective, longitudinal inception cohort of patients with idiopathic inflammatory myopathies, largely JDM. We sought to identify baseline factors that predict membership into different groups (latent classes) of disease activity trajectory.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 172 patients (64% females), with median age at diagnosis of 7.7\u2009years, were analysed. We studied 4725 visits (1471 patient-years). We identified three latent classes of longitudinal disease activity, as measured by the modified DAS (DASm), with distinct class trajectories predicted by DASm at baseline, and by the changes of DASm from either baseline to 3\u2009months or baseline to 6\u2009months (early response to therapy). In the analysis in which DASm at baseline and the changes of DASm from baseline to 6\u2009months are included as predictors, Class 1 (10%) has persistently high disease activity, Class 2 (34%) is characterized by moderate disease activity and Class 3 (56%) is characterized by individuals with a high early disease activity but an apparently good response to treatment and long-term low disease activity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>High early disease activity, and treatment resistance in the first few months, predict a more chronic longitudinal course of JDM.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae027","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T04:03:00Z","timestamp":1705118580000},"page":"SI129-SI135","source":"Crossref","is-referenced-by-count":8,"title":["Disease activity trajectories in juvenile dermatomyositis from childhood to adulthood"],"prefix":"10.1093","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7072-0463","authenticated-orcid":false,"given":"Tomo","family":"Nozawa","sequence":"first","affiliation":[{"name":"Division of Rheumatology, The Hospital for Sick Children , Toronto, ON, Canada"},{"name":"Department of Pediatrics, Yokohama City University Graduate School of Medicine , Yokohama City, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor M","family":"Pullenayegum","sequence":"additional","affiliation":[{"name":"Dalla Lana School of Public Health, University of Toronto , Toronto, ON, Canada"},{"name":"Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute , Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Bell-Peter","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, The Hospital for Sick Children , Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Anne","family":"Marcuz","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, The Hospital for Sick Children , Toronto, ON, Canada"},{"name":"Department of Rehabilitation, The Hospital for Sick Children , Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi","family":"Whitney","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, The Hospital for Sick Children , Toronto, ON, Canada"},{"name":"Department of Rehabilitation, The Hospital for Sick Children , Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ophir","family":"Vinik","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Saint Michael\u2019s Hospital , Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Shupak","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Saint Michael\u2019s Hospital , Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saunya","family":"Dover","sequence":"additional","affiliation":[{"name":"Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute , Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7813-9665","authenticated-orcid":false,"given":"Brian M","family":"Feldman","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, The Hospital for Sick Children , Toronto, ON, Canada"},{"name":"Dalla Lana School of Public Health, University of Toronto , Toronto, ON, Canada"},{"name":"Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute , Toronto, ON, Canada"},{"name":"Departments of Pediatrics and Institute of Health Policy Management & Evaluation, University of Toronto , Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,12]]},"reference":[{"key":"2024090907511688600_keae027-B1","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/rheumatology\/34.8.732","article-title":"The incidence of juvenile dermatomyositis: results from a nation-wide study","volume":"34","author":"Symmons","year":"1995","journal-title":"Br J Rheumatol"},{"key":"2024090907511688600_keae027-B2","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/art.11122","article-title":"US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry","volume":"49","author":"Mendez","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2024090907511688600_keae027-B3","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","article-title":"Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood","volume":"371","author":"Feldman","year":"2008","journal-title":"Lancet"},{"key":"2024090907511688600_keae027-B4","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/rheumatology\/kel099","article-title":"The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)-clinical characteristics of children recruited within the first 5 yr","volume":"45","author":"McCann","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"2024090907511688600_keae027-B5","first-page":"1198","article-title":"Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children","volume":"25","author":"Pachman","year":"1998","journal-title":"J Rheumatol"},{"key":"2024090907511688600_keae027-B6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-3476(64)80325-5","article-title":"Dermatomyositis","volume":"64","author":"Bitnum","year":"1964","journal-title":"J Pediatr"},{"key":"2024090907511688600_keae027-B7","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0022-3476(83)80706-9","article-title":"Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification","volume":"103","author":"Bowyer","year":"1983","journal-title":"J Pediatr"},{"key":"2024090907511688600_keae027-B8","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/ard.2005.045690","article-title":"Long-term outcome in polymyositis and dermatomyositis","volume":"65","author":"Bronner","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2024090907511688600_keae027-B9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0022-3476(84)80012-8","article-title":"Course of treated juvenile dermatomyositis","volume":"105","author":"Spencer","year":"1984","journal-title":"J Pediatr"},{"key":"2024090907511688600_keae027-B10","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1002\/art.23960","article-title":"Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features","volume":"58","author":"Stringer","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2024090907511688600_keae027-B11","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/rheumatology\/kep302","article-title":"Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset","volume":"48","author":"Sanner","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"2024090907511688600_keae027-B12","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/acr.20203","article-title":"Long-term muscular outcome and predisposing and prognostic factors in juvenile dermatomyositis: a case-control study","volume":"62","author":"Sanner","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2024090907511688600_keae027-B13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/ard.2010.131433","article-title":"Pulmonary outcome in juvenile dermatomyositis: a case-control study","volume":"70","author":"Sanner","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2024090907511688600_keae027-B14","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/ard.2010.137968","article-title":"Cardiac dysfunction in juvenile dermatomyositis: a case-control study","volume":"70","author":"Schwartz","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2024090907511688600_keae027-B15","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/acr.21637","article-title":"Quality of life in adults with juvenile-onset dermatomyositis: a case-control study","volume":"64","author":"Tollisen","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2024090907511688600_keae027-B16","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/rheumatology\/keu146","article-title":"Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool","volume":"53","author":"Sanner","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"2024090907511688600_keae027-B17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1529-0131(200003)43:3<541::AID-ANR9>3.0.CO;2-T","article-title":"Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis","volume":"43","author":"Huber","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2024090907511688600_keae027-B18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12969-017-0148-2","article-title":"Methods for analyzing observational longitudinal prognosis studies for rheumatic diseases: a review & worked example using a clinic-based cohort of juvenile dermatomyositis patients","volume":"15","author":"Lim","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"key":"2024090907511688600_keae027-B19","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/rheumatology\/keaa497","article-title":"Identification and prediction of novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture models","volume":"60","author":"Deakin","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2024090907511688600_keae027-B20","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.40320","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups","volume":"69","author":"Lundberg","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2024090907511688600_keae027-B21","first-page":"567","author":"Curran"},{"key":"2024090907511688600_keae027-B22","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1002\/art.21378","article-title":"The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids","volume":"52","author":"Ramanan","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2024090907511688600_keae027-B23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3899\/jrheum.191255","article-title":"Correlation of a Modified Disease Activity Score (DAS) with the Validated Original DAS in Patients with Juvenile Dermatomyositis","volume":"48","author":"Clairman","year":"2021","journal-title":"J Rheumatol"},{"key":"2024090907511688600_keae027-B24","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jclinepi.2007.10.024","article-title":"Fitting marginal structural models: estimating covariatetreatment associations in the reweighted data set can guide model fitting","volume":"61","author":"Pullenayegum","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"2024090907511688600_keae027-B25","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/rheumatology\/keq407","article-title":"Nailfold capillary density is importantly associated over time with muscle and skin disease activity in juvenile dermatomyositis","volume":"50","author":"Schmeling","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"2024090907511688600_keae027-B26","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/art.20179","article-title":"Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies","volume":"50","author":"Huber","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2024090907511688600_keae027-B27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","article-title":"Group-based trajectory modeling in clinical research","volume":"6","author":"Nagin","year":"2010","journal-title":"Ann Rev Clin Psychol"},{"key":"2024090907511688600_keae027-B28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.0006-341X.1999.00463.x","article-title":"Finite mixture modeling with mixture outcomes using the EM algorithm","volume":"55","author":"Muthen","year":"1999","journal-title":"Biometrics"},{"key":"2024090907511688600_keae027-B29","author":"Gentleman","year":"2022"},{"key":"2024090907511688600_keae027-B30","author":"Proust-Lima","year":"2018"},{"key":"2024090907511688600_keae027-B31","author":"van Buuren","year":"2019"},{"key":"2024090907511688600_keae027-B32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v075.i07","article-title":"Just another Gibbs additive modeler: interfacing JAGS and mgcv","volume":"75","author":"Wood","year":"2016","journal-title":"J Stat Softw"},{"key":"2024090907511688600_keae027-B33","author":"Yee","year":"2022"},{"key":"2024090907511688600_keae027-B34","first-page":"507","article-title":"Generalized additive models for location, scale and shape, (with discussion)","volume":"54","author":"Rigby","year":"2005","journal-title":"Appl Stat"},{"key":"2024090907511688600_keae027-B35","first-page":"1250","article-title":"Early abnormal nailfold capillary changes are predictive of calcinosis development in juvenile dermatomyositis","volume":"49","author":"Nozawa","year":"2022","journal-title":"J Rheumatol"},{"key":"2024090907511688600_keae027-B36","doi-asserted-by":"crossref","first-page":"152104","DOI":"10.1016\/j.semarthrit.2022.152104","article-title":"The clinical features of juvenile dermatomyositis: a single-centre inception cohort","volume":"57","author":"Cancarini","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"2024090907511688600_keae027-B37","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/art.39466","article-title":"Brief report: association of myositis autoantibodies, clinical features, and environmental exposures at illness onset with disease course in juvenile myositis","volume":"68","author":"Habers","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2024090907511688600_keae027-B38","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1093\/rheumatology\/keaa371","article-title":"Corticosteroid discontinuation, complete clinical response and remission in juvenile dermatomyositis","volume":"60","author":"Kishi","year":"2021","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae027\/56427890\/keae027.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/SI2\/SI129\/59038548\/keae027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/SI2\/SI129\/59038548\/keae027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T07:52:08Z","timestamp":1725868328000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/63\/SI2\/SI129\/7521405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,12]]},"references-count":38,"journal-issue":{"issue":"SI2","published-online":{"date-parts":[[2024,1,12]]},"published-print":{"date-parts":[[2024,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae027","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,1,12]]}}}